Balance Sheet Data

Biogen Inc. (BIIB)

$292.15

+0.68 (+0.23%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 3,6893,5384,475.902,610.103,802.503,043.642,980.272,918.222,857.462,797.96
Total Cash (%)
Account Receivables 2,319.602,485.402,470.702,327.301,961.701,929.771,889.591,850.241,811.721,774
Account Receivables (%)
Inventories 902.70929.90804.201,068.601,351.50862.72844.76827.17809.95793.08
Inventories (%)
Accounts Payable 395.50370.50530.80454.90589.20396.08387.83379.75371.85364.10
Accounts Payable (%)
Capital Expenditure -1,962.80-886.10-669.50-551.80-294.90-731.73-716.50-701.58-686.97-672.67
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.